ENDV
ENDONOVO THERAPEUTICS, INC.
0.00 (0.00%)0.00USD40.0K成交股數32K市值–本益比(近四季)0.1股價營收比-86.1%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 23Q3 | 23Q2 | 23Q1 | 22Q3 | 22Q2 | 22Q1 | 21Q4 | 21Q3 | 21Q2 | 21Q1 | 20Q3 | 20Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 2K+134% | 45K+1881% | 88K+27603% | 11K+41% | 650.00-98% | 2K-93% | 316.00-99% | 8K-83% | 30K | 35K | 40K | 45K |
| 營業成本 | 827.00 | – | 4K | 4K | 383.00 | 714.00 | 9K | 3K | 500.00 | 3K | 760.00 | 11K |
| 毛利 | 693.00+160% | 45K+2783% | 84K-1078% | 7K+48% | 267.00-99% | 2K-95% | −9K-122% | 5K-86% | 30K | 32K | 39K | 33K |
| 毛利率 | 45.6% | 100.0% | 95.4% | 63.3% | 41.1% | 68.7% | -2,704.1% | 60.2% | 98.3% | 92.7% | 98.1% | 74.7% |
| 研發費用 | – | – | – | – | – | – | – | – | – | 0 | 0 | – |
| 銷售管理費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業利益 | −473K-74% | −1.1M+133% | −529K+42% | −497K-28% | −1.8M+216% | −486K-18% | −374K-61% | −692K+15% | −570K | −590K | −947K | −602K |
| 營業利益率 | -31,105.1% | -2,502.9% | -604.6% | -4,532.6% | -276,730.6% | -21,286.7% | -118,289.2% | -8,886.5% | -1,882.4% | -1,700.8% | -2,368.2% | -1,348.4% |
| 稅後淨利 | −766K-70% | 2.1M-186% | 7.2M+202% | −603K-60% | −2.5M+95% | −2.4M-10% | 2.4M-324% | −1.5M-7% | −1.3M | −2.7M | −1.1M | −1.6M |
| 淨利率 | -50,405.9% | 4,565.6% | 8,259.7% | -5,505.1% | -388,635.5% | -105,749.7% | 758,332.3% | -19,559.4% | -4,281.7% | -7,722.5% | -2,673.9% | -3,662.6% |
| 稀釋 EPS | 0.00-100% | -0.01-67% | 0.00-100% | 0.00-100% | -0.020% | -0.03-50% | 0.05-171% | -0.02-88% | -0.02 | -0.06 | -0.07 | -0.17 |
| 稀釋股數 | 1.35B | 1.35B | 1.74B | 154M | 134M | 79.0M | 59.8M | 66.3M | 58.5M | 41.6M | 16.1M | 9.8M |
資產負債表 期末餘額
| 科目 | 23Q3 | 23Q2 | 23Q1 | 22Q3 | 22Q2 | 22Q1 | 21Q4 | 21Q3 | 21Q2 | 21Q1 | 20Q3 | 20Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 0 | 33K | 11K | 23K | – | 60K | 86K | 6K | 9K | 86K | 3K | 5K |
| 應收帳款 | – | – | 3K | 944.00 | 945.00 | 945.00 | 944.00 | 7K | 9K | 7K | 942.00 | 941.00 |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 816K | 1.0M | 1.2M | 1.5M | 1.6M | 1.8M | 2.0M | 2.1M | 2.3M | 2.5M | 2.7M | 2.9M |
| 有息負債 | 7.1M | 7.1M | 6.9M | 7.3M | 7.4M | 7.4M | 7.3M | 6.8M | 6.7M | 6.8M | 6.2M | 6.2M |
| 總負債 | 23.8M | 23.2M | 25.6M | 21.1M | 20.8M | 19.9M | 17.8M | 20.4M | 19.3M | 18.5M | 15.5M | 15.1M |
| 股東權益 | −23.0M | −22.4M | −24.4M | −19.6M | −19.2M | −18.0M | −15.8M | −18.2M | −17.0M | −16.0M | −12.8M | −12.2M |
| 負債比 | 2,914.6% | 2,287.8% | 2,132.6% | 1,451.0% | 1,301.4% | 1,093.7% | 885.9% | 952.7% | 846.7% | 733.4% | 567.1% | 520.7% |
| 淨現金(現金 − 有息負債) | −7.1M | −7.0M | −6.9M | −7.2M | – | −7.3M | −7.2M | −6.8M | −6.7M | −6.8M | −6.2M | −6.2M |
現金流量表 單季
| 科目 | 23Q3 | 23Q2 | 23Q1 | 22Q3 | 22Q2 | 22Q1 | 21Q4 | 21Q3 | 21Q2 | 21Q1 | 20Q3 | 20Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | −173K | – | – | −123K-58% | – | – | – | −290K | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | 162K | – | – | – | 163K | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2022 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2022 年度 · 135K
| Royalty | 114K | 83.9% | – |
|---|---|---|---|
| Direct Sales Medical Care Providers Gross | 22K | 16.1% | -70.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2022 | 135K | +85.2% | −18.5M | -13,649.2% | – | – |
| FY2021 | 73K | -55.9% | −3.1M | -4,247.2% | -0.05 | – |
| FY2020 | 166K | -46.5% | −396K | -238.6% | -0.03 | – |
| FY2019 | 310K | +272.5% | −17.3M | -5,582.4% | -24.83 | −2.5M |
| FY2018 | 83K | – | −6.4M | -7,729.5% | -17.76 | −2.9M |